Literature DB >> 8700304

Epidemiological and genetic studies of Huntington's disease in the San-in area of Japan.

K Nakashima1, Y Watanabe, M Kusumi, E Nanba, Y Maeoka, M Nakagawa, M Igo, H Irie, H Ishino, A Fujimoto, J Goto, K Takahashi.   

Abstract

After the DNA diagnosis, we evaluated the prevalence of Huntington's disease (HD) in the San-in area of Japan, and confirmed the founder effect. There were 10 patients with HD in the San-in area, who were diagnosed clinically. The expansion of the CAG repeat was observed in 9 patients with HD members in their families, although those family members of the patients had already died. In the patient who had no positive family history, expansion of the CAG repeat was not seen. The prevalence of HD was 065/100,000 in this area. The common haplotype studied by the polymorphism marker of D4S136 was shown in all 9 HD patients, although they were observed in only 2.7% of the normal population. These results suggested a common ancestor of these HD patients.

Entities:  

Mesh:

Year:  1996        PMID: 8700304     DOI: 10.1159/000109899

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  9 in total

1.  Junctophilin 3 (JPH3) expansion mutations causing Huntington disease like 2 (HDL2) are common in South African patients with African ancestry and a Huntington disease phenotype.

Authors:  Amanda Krause; Claire Mitchell; Fahmida Essop; Susan Tager; James Temlett; Giovanni Stevanin; Christopher Ross; Dobrila Rudnicki; Russell Margolis
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2015-06-16       Impact factor: 3.568

2.  HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia.

Authors:  Simon C Warby; Henk Visscher; Jennifer A Collins; Crystal N Doty; Catherine Carter; Stefanie L Butland; Anna R Hayden; Ichiro Kanazawa; Colin J Ross; Michael R Hayden
Journal:  Eur J Hum Genet       Date:  2011-01-19       Impact factor: 4.246

3.  Clinical and genetic data of Huntington disease in Moroccan patients.

Authors:  Ahmed Bouhouche; Wafaa Regragui; Hind Lamghari; Khadija Khaldi; Nazha Birouk; Safaa Lytim; Soufiane Bellamine; Yamna Kriouile; Naima Bouslam; El Hachmia Ait Ben Haddou; Mustapha Alaoui Faris; Ali Benomar; Mohamed Yahyaoui
Journal:  Afr Health Sci       Date:  2015-12       Impact factor: 0.927

Review 4.  Therapeutic approaches to preventing cell death in Huntington disease.

Authors:  Anna Kaplan; Brent R Stockwell
Journal:  Prog Neurobiol       Date:  2012-08-28       Impact factor: 11.685

5.  CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup.

Authors:  Simon C Warby; Alexandre Montpetit; Anna R Hayden; Jeffrey B Carroll; Stefanie L Butland; Henk Visscher; Jennifer A Collins; Alicia Semaka; Thomas J Hudson; Michael R Hayden
Journal:  Am J Hum Genet       Date:  2009-02-26       Impact factor: 11.025

6.  Huntington's like conditions in China, A review of published Chinese cases.

Authors:  Zhenzhen Zheng; Jean-Marc Burgunder; Huifang Shang; Xiaoyan Guo
Journal:  PLoS Curr       Date:  2012-02-09

7.  Current Status of Huntington's Disease in Korea: A Nationwide Survey and National Registry Analysis.

Authors:  Hyun Sook Kim; Chul Hyoung Lyoo; Phil Hyu Lee; Sang Jin Kim; Mee Young Park; Hyeo-Il Ma; Jae Hyeok Lee; Sook Kun Song; Jong Sam Baik; Jin Ho Kim; Myung Sik Lee
Journal:  J Mov Disord       Date:  2015-01-13

8.  Clinical and Genetic Profiles in Chinese Patients with Huntington's Disease: A Ten-year Multicenter Study in China.

Authors:  Hong-Lei Li; Xiao-Yan Li; Yi Dong; Yan-Bin Zhang; Hong-Rong Cheng; Shi-Rui Gan; Zhi-Jun Liu; Wang Ni; Jean-Marc Burgunder; X William Yang; Zhi-Ying Wu
Journal:  Aging Dis       Date:  2019-10-01       Impact factor: 6.745

9.  CAG-Expansion Haplotype Analysis in a Population with a Low Prevalence of Huntington's Disease.

Authors:  Teeratorn Pulkes; Chutima Papsing; Sukanya Wattanapokayakit; Surakameth Mahasirimongkol
Journal:  J Clin Neurol       Date:  2014-01-06       Impact factor: 3.077

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.